---
figid: PMC4111689__cc-13-2017-g1
figtitle: Targeting the Achilles’ heel of drug-resistant cancer stem cells
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC4111689
filename: cc-13-2017-g1.jpg
figlink: /pmc/articles/PMC4111689/figure/F1/
number: F1
caption: Figure 1. Integrin β3 drives EGFR TKI resistance. Integrin β3 interacts with
  KRAS to promote RalB activation, resulting in the activation of the NFκB pathway
  and thereby promoting cell survival. Importantly, ligation of integrin is not required
  for this signaling cascade. The inhibition of this non-canonical pathway sensitizes
  β3-positive tumor cells to EGFR TKI. Pharmacologic inhibition of this pathway can
  reverse cancer stemness and drug resistance.
papertitle: Targeting the Achilles’ heel of drug-resistant cancer stem cells.
reftext: Laetitia Seguin, et al. Cell Cycle. 2014 Jul 1;13(13):2017-2018.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9530089
figid_alias: PMC4111689__F1
figtype: Figure
redirect_from: /figures/PMC4111689__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4111689__cc-13-2017-g1.html
  '@type': Dataset
  description: Figure 1. Integrin β3 drives EGFR TKI resistance. Integrin β3 interacts
    with KRAS to promote RalB activation, resulting in the activation of the NFκB
    pathway and thereby promoting cell survival. Importantly, ligation of integrin
    is not required for this signaling cascade. The inhibition of this non-canonical
    pathway sensitizes β3-positive tumor cells to EGFR TKI. Pharmacologic inhibition
    of this pathway can reverse cancer stemness and drug resistance.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EEF1B2P2
  - BHLHE22
  - MTG1
  - KRAS
  - NRAS
  - EGFR
  - RALB
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - rb
  - betaTub60D
  - Prosbeta3
  - Egfr
  - Dif
  - dl
  - Rel
---
